Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage

Current — Sun Pharmaceutical Industries, Inc.

The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Sun Pharmaceutical Industries, Inc. with status Current. The shortage was first posted on Jul 14, 2023. Reported reason: Other

Shortage details

Status
Current
Company
Sun Pharmaceutical Industries, Inc.
Package NDC
57664-048-88
Dosage Form
Capsule
Presentation
Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 57664-048-88)
Initial Posting
Jul 14, 2023

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.